| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,788 |
5,155 |
$235K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,491 |
4,807 |
$131K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,438 |
7,025 |
$113K |
| 80061 |
Lipid panel |
7,109 |
6,721 |
$88K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,147 |
11,138 |
$86K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,967 |
2,808 |
$81K |
| 80053 |
Comprehensive metabolic panel |
7,390 |
6,922 |
$70K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,954 |
4,699 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,145 |
1,779 |
$43K |
| 81000 |
|
8,647 |
8,117 |
$25K |
| 86738 |
|
1,777 |
1,681 |
$22K |
| 82274 |
|
1,454 |
1,363 |
$21K |
| 86328 |
|
810 |
767 |
$20K |
| 82043 |
|
2,893 |
2,708 |
$17K |
| 84436 |
|
2,318 |
2,189 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
274 |
228 |
$14K |
| 82607 |
|
942 |
863 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
263 |
258 |
$13K |
| 84479 |
|
2,251 |
2,112 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
3,365 |
2,871 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,569 |
1,480 |
$12K |
| 84153 |
|
705 |
676 |
$12K |
| 87088 |
|
1,505 |
1,399 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,509 |
1,403 |
$10K |
| 86701 |
|
943 |
892 |
$9K |
| 80074 |
|
142 |
128 |
$7K |
| 84439 |
|
701 |
639 |
$6K |
| 85651 |
|
1,052 |
978 |
$3K |
| 82378 |
|
200 |
186 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
105 |
101 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
93 |
89 |
$3K |
| 86592 |
|
683 |
645 |
$3K |
| 82947 |
|
317 |
310 |
$1K |
| 82270 |
|
319 |
312 |
$1K |
| 85730 |
|
188 |
168 |
$993.02 |
| 85610 |
|
233 |
210 |
$807.99 |
| 86140 |
|
178 |
160 |
$734.21 |
| 82465 |
|
136 |
136 |
$539.35 |
| 86038 |
|
43 |
37 |
$479.23 |
| 84478 |
|
85 |
85 |
$446.34 |
| 86304 |
|
13 |
12 |
$130.94 |
| 82565 |
|
29 |
28 |
$124.09 |
| 80050 |
General health panel |
12 |
12 |
$120.34 |
| 84520 |
|
27 |
26 |
$87.78 |
| 82950 |
|
16 |
16 |
$71.64 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
570 |
528 |
$0.00 |